Ibrutinib price in India (2026)
Bangladesh list prices converted into INR, plus the registration rules of the CDSCO, the legal import routes and the real cost build-up for India.
Quick answer: ibrutinib price in India
Bangladeshi list price for generic ibrutinib140 mg is BDT 320–BDT 750 per unit (about INR 249.53–INR 584.83), i.e. INR 7,486–INR 17,545 per 30-unit month; add freight, duty and distributor margin for $India.
FX basis: 1 USD = 122.87 BDT (September 2026). Conversions are indicative only — the binding price is your supplier quotation.
Currency conversion
| Item | BDT | INR | USD |
|---|---|---|---|
| Lowest unit price | BDT 320 | INR 249.53 | US$2.60 |
| Highest unit price | BDT 750 | INR 584.83 | US$6.10 |
| 30-unit month (lowest) | BDT 9,600 | INR 7,486 | US$78.13 |
| 30-unit month (highest) | BDT 22,500 | INR 17,545 | US$183.12 |
Bangladesh benchmark (world reference price)
Registered brands and list prices for this molecule in Bangladesh (DGDA registration, via MedEx).
| Brand | Manufacturer | Strength | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Ibrunib Lowest | Jenphar Bangladesh Ltd. | 140 mg Capsule | BDT 320 | US$2.60 | 1 x 60: ৳ 19,200.00 |
| Ibruxen | Everest Pharmaceuticals Ltd. | 140 mg Capsule | BDT 350 | US$2.85 | 1 x 30: ৳ 10,500.00 |
| Butinib | Drug International Ltd. | 140 mg Capsule | BDT 500 | US$4.07 | 3 x 10: ৳ 15,000.00 |
| Ibrucent | Incepta Pharmaceuticals Ltd. | 140 mg Capsule | BDT 500 | US$4.07 | 3 x 4: ৳ 6,000.00 |
| Ibrucon | Beacon Pharmaceuticals PLC | 140 mg Capsule | BDT 600 | US$4.88 | 4 x 6: ৳ 14,400.00 |
| Ibrutab | Eskayef Pharmaceuticals Ltd. | 140 mg Tablet | BDT 600 | US$4.88 | 2 x 14: ৳ 16,800.00 |
| Ibutigen | General Pharmaceuticals Ltd. | 140 mg Capsule | BDT 600 | US$4.88 | 1 x 120: ৳ 72,000.00 |
| Notafol | Genvio Pharma Ltd. | 140 mg Capsule | BDT 750 | US$6.10 | 9 x 10: ৳ 67,500.00 |
Source: MedEx Bangladesh drug registry (list prices of DGDA-registered brands). Unit prices move with pack size, pharmacy and exchange rate — reference only. Original registry page
Import and regulatory notes
Central Drugs Standard Control Organisation (CDSCO). India is the largest generic producer in the world but a section of the oncology and biologic market is still originator-priced. Indian generics of recent molecules appear only after the local patent position allows (India issues compulsory licences case by case), so availability of the newest molecules lags Bangladesh. Prices are quoted as MRP per pack in INR.
How to obtain it legally
- Obtain a prescription plus the diagnostic/genetic report from the treating physician (e.g. the target-mutation result).
- Confirm the exact brand and strength, and ask the supplier for the batch number, certificate of analysis (COA) and the manufacturer's GMP credentials.
- Clear the shipment through a CDSCO-licensed importer or pharmacy; unregistered products go through the named-patient route.
- Check batch number, expiry and packaging on arrival, then follow the prescriber's monitoring schedule.
What adds to the price when you import
- International freight and cold chain (monoclonal antibodies and insulins need 2–8°C end-to-end).
- Customs duty and import VAT in India.
- Compliance, licensing and warehousing cost of the importer/distributor (typically 10–30%).
- Order size and pack configuration — full cases price below retail strips.
- Exchange-rate movement: this page converts at 1 USD = 122.87 BDT.
Frequently asked questions
How much does ibrutinib cost in India?
There is no fixed public retail price for ibrutinib in India in the sources we track (most supply is hospital- or named-patient based). Use the Bangladesh list price as the benchmark: BDT 320–BDT 750 (US$2.60–US$6.10) per unit, about INR 249.53–INR 584.83 in INR per unit and INR 7,486–INR 17,545 per 30-unit month, before freight, customs duty and distributor margin.
Can I legally import ibrutinib into India?
Yes, but only through the rules of the Central Drugs Standard Control Organisation (CDSCO): India is the largest generic producer in the world but a section of the oncology and biologic market is still originator-priced. Indian generics of recent molecules appear only after the local patent position allows (India issues compulsory licences case by case), so availability of the newest molecules lags Bangladesh. Prices are quoted as MRP per pack in INR. Prescription medicines must move on a valid prescription through a licensed importer, pharmacy or hospital; personal-use imports need a named-patient / compassionate-use authorisation.
Are Bangladeshi or Indian generics of ibrutinib approved in India?
We cannot confirm the registration status of every individual generic brand in India. Central Drugs Standard Control Organisation (CDSCO) is the approving authority, and only products with a local product registration (or a special import authorisation) may be sold routinely. Ask your supplier for the local registration or import permit for the specific brand before you buy.
Why is the Bangladesh price a useful reference?
Bangladesh is a least-developed-country WTO member with a pharmaceutical patent exemption running to 2033, so local manufacturers can legally produce molecules that are still on patent elsewhere — and DGDA-registered list prices are public. That makes it the practical global floor price for on-patent targeted therapy and the benchmark used in import negotiations.
This molecule in other markets
This page is an information resource for healthcare professionals, licensed importers and patients under medical care. It is not medical advice, not a prescription service, and not an offer to sell prescription medicines to the public.
Also sourced for India
Need a verified quotation?
Send us the molecule, strength, pack size, quantity and destination country. We reply with a batch-traceable quotation, certificates of analysis and shipping documentation.
We supply licensed pharmacies, hospitals, importers and distributors — not direct-to-consumer patients.